Publicador de contenidos

Back to 20210921_CIE_noche_investigadores

The Science Museum of the University of Navarra moves to New York to celebrate the European Researchers' Night

The Science Museum has organized an online colloquium with the Navarrese scientists Amaia Lujambio and Javier Carmona, residents in New York.

21 | 09 | 2021

The Science Museum of the University of Navarra joins the celebration of the "European Researchers' Night" next Friday, September 24. And it does so with an online colloquium with Amaia Lujambio and Javier Carmona, two Spanish scientists living in New York. The session, entitled "Parallel trajectories, different destinations?"will be held at 19:30 (Spanish time) on the Science Museum's YouTube channel.

Amaia Lujambio (Goizueta, 39 years old) and Javier Carmona (Pamplona, 37 years old) studied Biology at the Faculty of Sciences of the University of Navarra, did their doctoral thesis in the same laboratory, and coincided at Sloan Kettering in New York during their postdoctoral studies. Currently, these two scientists are developing their careers in the field of medicine in this city. Amaia is a professor at the Icahn School of Medicine at Mount Sinai and Javier is a senior editor at Nature Medicine.

The session will be moderated by Ujué Moreno, professor of the Department of Biochemistry and Genetics of the Faculty of Sciences of the University of Navarra and researcher at Cima.

The European Researchers' Night is an annual event in which universities and scientific institutions in more than 300 cities in Europe organize various activities to bring the work of scientists closer to society.

More information about the speakers

- Amaia Lujambio. Graduated in Biology at the University of Navarra (2005), she did her PhD thesis at the Autonomous University of Madrid, where she studied the epigenetic regulation of microRNAs in cancer, under the supervision of Dr. Manel Esteller (CNIO). She continued her studies in cancer in New York, in the laboratory of Scott Lowe, where she specialized in the development of preclinical models for the study of mechanisms contributing to cancer. Since 2014 he has been working in the laboratory at the Icahn School of Medicine at Mount Sinai where he studies liver cancer. His research is funded by the National Cancer Institute and other foundations.

- Javier Carmona. He began his studies in Biology at the University of Navarra and graduated from the Autonomous University of Madrid in 2007. He developed his PhD thesis in the laboratory of Dr. Manel Esteller, studying epigenetic alterations in the process of metastasis, and in 2013 he joined the laboratory of Dr. José Baselga at Memorial Sloan Kettering Cancer Center in New York, where he investigated on the mechanisms of resistance to therapies in breast cancer patients. Since 2016 he is an editor at Nature Medicine where he coordinates the areas of oncology and artificial intelligence applied to medicine.

- Ujué Moreno. D. in Cellular and Molecular Biology from the University of Navarra, professor in the Department of Biochemistry and Genetics at the University of Navarra, where she teaches on genetic engineering. She is part of the research group on heart failure at Cima, where she studies the molecular bases that promote the development and poor prognosis of this pathology.